|
Almeida Capital is pleased to be a premier sponsor of AltAssets
|
FREE newsletter RSS
INTELLIGENCE
RECRUITMENT
KNOWLEDGE BANK
EVENTS
SECTOR ANALYSIS
HEDGE FUNDS
|
PRINT THIS PAGE Adele Cirone Oliva joins Quaker BioVentures from Apax21/05/2007. Source: AltAssets. 
 Quaker BioVentures, a venture capital firm dedicated to investing in life science companies in the US Mid-Atlantic region, has appointed Adele Cirone Oliva as a partner.
Oliva most recently served as co-head of US Healthcare at Apax Partners. Previously, Oliva was in product management and business development in the IV Systems Division and the Cardiovascular Group at Baxter Healthcare.
'Having grown up in Philadelphia, in the heart of the nation's pharmaceutical industry, and investing globally in healthcare for the past ten years, I have tremendous admiration for the work that the venture and life science communities are doing in the Mid-Atlantic,' said Oliva. 'There is tremendous potential in this region. And since its inception five years ago, Quaker BioVentures has become a top life science venture capital firm with a highly focused investment strategy. Their work has been critical in accelerating the development of the Mid-Atlantic as a key hub for life science companies.'
'Adele is coming to Quaker with an exceptional background at one of the leading private equity firms, and with strong investment experience in the healthcare sector,' added Sherrill Neff, a partner of Quaker BioVentures. 'As Quaker BioVentures begins to invest from our second fund, her expertise in medical devices, specialty pharmaceuticals, and larger growth financings will complement Quaker BioVentures' traditional early-stage focus, and cultivate new investment opportunities.'
Quaker BioVentures has $450m under management.
Copyright © 2007 AltAssets
|
 
|
|
|
